PRKCA and urinary bladder carcinoma: For example, the overexpression of PKCα has been demonstrated in prostate, endometrial, and high-grade urinary bladder carcinoma [144] while downregulation of PKCα has been described in basal cell carcinoma and colon cancers [145, 146].